MLIC—54

Misr Life Insurance Co

Life & Health InsuranceVerified

Misr Life Insurance Co has a fully diluted share count of 500,000,000 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available for Misr Life Insurance Co, as no financial data has been provided for comparison against industry benchmarks or cohort medians. The company's geographic and segmental revenue exposure is not disclosed in the available data, making it impossible to assess revenue concentration or diversification. Growth trajectory data is not available for Misr Life Insurance Co, as no revenue history or outlook figures have been provided for the current or next fiscal year. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and no going-concern language in source documents. Dilution risk is currently low, as there is no difference between basic and diluted shares outstanding. No recent events, such as filings or transcripts, are available in the provided data to inform the company's current strategic or operational developments.

30-day price · MLIC+0.00 (+0.0%)

Low$10.00High$10.00Close$10.00As of17 May, 00:00 UTC

Profile

CompanyMisr Life Insurance Co

TickerMLIC.CA

SectorFinancials

BusinessInsurance

Industry groupInsurance

IndustryLife & Health Insurance

AI analysis

Business. Misr Life Insurance Co provides life and health insurance products and services in Egypt and the broader Middle East region.

Classification. Misr Life Insurance Co is classified under the Financials economic sector, Insurance business sector, and Life & Health Insurance industry with a confidence level of 0.92.

Key takeaways

Misr Life Insurance Co has no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible securities.
Liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
No financial data is available to assess profitability or return metrics against industry benchmarks.
No revenue concentration or geographic exposure data is available to evaluate diversification.
No growth trajectory or revenue history is available to assess future performance.
--
## RATIONALES
```json

Financial snapshot

PeriodHA-latest

CurrencyUSD

Revenue—

Gross profit—

Operating income—

Net income—

R&D—

SG&A—

D&A—

SBC—

Operating cash flow—

CapEx—

Free cash flow—

Total assets—

Total liabilities—

Total equity—

Cash & equivalents—

Long-term debt—

Annual history (last 5)

PeriodRevenueOp IncomeNet IncomeFCF

FY-4————

FY-3————

FY-2————

FY-1————

FY0————

PeriodGross %Op %Net %FCF %

FY-4————

FY-3————

FY-2————

FY-1————

FY0————

PeriodAssetsEquityCashDebt

FY-4————

FY-3————

FY-2————

FY-1————

FY0————

PeriodOCFCapExFCFSBC

FY-4————

FY-3————

FY-2————

FY-1————

FY0————

Quarterly history (last 4)

PeriodRevenueOp IncomeNet IncomeFCF

FQ-7————

FQ-6————

FQ-5————

FQ-4————

FQ-3————

FQ-2————

FQ-1————

FQ0————

PeriodGross %Op %Net %FCF %

FQ-7————

FQ-6————

FQ-5————

FQ-4————

FQ-3————

FQ-2————

FQ-1————

FQ0————

PeriodAssetsEquityCashDebt

FQ-7————

FQ-6————

FQ-5————

FQ-4————

FQ-3————

FQ-2————

FQ-1————

FQ0————

PeriodOCFCapExFCFSBC

FQ-7————

FQ-6————

FQ-5————

FQ-4————

FQ-3————

FQ-2————

FQ-1————

FQ0————

Valuation

Market price—

Market cap—

Enterprise value—

P/E—

Reported non-GAAP P/E—

EV/Revenue—

EV/Op income—

EV/OCF—

P/B—

P/Tangible book—

Tangible book—

Net cash—

Current ratio—

Debt/Equity—

ROA—

ROE—

Cash conversion—

CapEx/Revenue—

SBC/Revenue—

Asset intensity—

Dilution ratio0.0%

Risk assessment

Dilution riskLow

Liquidity riskUnknown

Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).

Industry benchmarks

Activity: Life & Health Insurance · cohort 15 companies

MetricMLICActivity

Op margin—12.3% medp25 5.6% · p75 21.6%

Net margin—2.9% medp25 0.5% · p75 10.1%

Gross margin—28.2% medp25 13.4% · p75 30.5%

CapEx / revenue—-2.1% medp25 -8.2% · p75 -1.2%

Debt / equity—27.5% medp25 4.7% · p75 66.5%

Source data

Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.

Company fundamentalsperiod FQ-7 · history via verified-market-data

no public URL

2026-05-10 09:58 UTC#e07a421f

Source: analysis-pipeline (hybrid)Generated: 2026-05-28 14:28 UTCJob: 26e37b46